Alzheimer’s AI Biotech IGC Pharma, Inc. (NYSE: IGC) Stock in Focus – QTEX, LFS, BIYA, ANY, PCLA Inside
IGC Pharma, Inc. (NYSE: IGC) a clinical-stage biotechnology company developing AI-powered Alzheimer’s disease therapies, is gaining investor attention after reporting Q1 2026 financial results and continued progress in its ongoing…
